Medical Developments International reported AUD12.94M in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 845K 162K Dec/2024
Avita Medical AUD 21.23M 2.57M Dec/2024
Clinuvel Pharmaceuticals AUD 16.21M 3.62M Jun/2024
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Genetic Signatures AUD 10.52M 1.03M Dec/2024
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
Medical Developments International AUD 12.94M 5.87M Dec/2024
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024
Organon & Co USD 453M 33M Jun/2025
Paradigm Biopharmaceuticals AUD 2.36M 639.57K Dec/2024
PYC Therapeutics AUD 2.58M 1.57M Dec/2024
Starpharma Holdings AUD 3.13M 1.31M Dec/2024
Tectonic Therapeutic USD 5.15M 315K Jun/2025
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024
Viatris USD 928.7M 111.2M Jun/2025
Xeris Pharmaceuticals USD 44.39M 35.89M Jun/2025